5VM
JANX icon

5AM Venture Management’s Janux Therapeutics JANX Stock Holding History

5AM Venture Management’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-446,266
Closed -$5.88M – 25
2022
Q4 		$5.88M Hold
446,266
– – 1.58% 18
2022
Q3 		$6.04M Hold
446,266
– – 1.16% 17
2022
Q2 		$5.45M Hold
446,266
– – 1.35% 17
2022
Q1 		$6.4M Hold
446,266
– – 1.4% 15
2021
Q4 		$8.8M Hold
446,266
– – 1.65% 14
2021
Q3 		$9.65M Hold
446,266
– – 1.96% 13
2021
Q2 		$11.1M Buy
+446,266
New +$9.94M 2.8% 10

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return